Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

Transcriptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats.

Grünblatt E, Schmidt WJ, Scheller DK, Riederer P, Gerlach M.

J Neural Transm (Vienna). 2011 Dec;118(12):1717-25. doi: 10.1007/s00702-010-0552-y. Epub 2010 Dec 25.

PMID:
21188436
2.

The role of NMDA and AMPA/Kainate receptors in the consolidation of catalepsy sensitization.

Riedinger K, Kulak A, Schmidt WJ, von Ameln-Mayerhofer A.

Behav Brain Res. 2011 Mar 17;218(1):194-9. doi: 10.1016/j.bbr.2010.11.055. Epub 2010 Dec 3.

PMID:
21130808
3.

Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.

Alam M, Danysz W, Schmidt WJ, Dekundy A.

Toxicol Appl Pharmacol. 2009 Oct 15;240(2):198-207. doi: 10.1016/j.taap.2009.07.010. Epub 2009 Jul 17.

PMID:
19616571
4.

Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition.

Schlumberger C, Schäfer D, Barberi C, Morè L, Nagel J, Pietraszek M, Schmidt WJ, Danysz W.

Behav Pharmacol. 2009 Feb;20(1):56-66. doi: 10.1097/FBP.0b013e3283242f57.

PMID:
19179851
5.

A neurocomputational account of catalepsy sensitization induced by D2 receptor blockade in rats: context dependency, extinction, and renewal.

Wiecki TV, Riedinger K, von Ameln-Mayerhofer A, Schmidt WJ, Frank MJ.

Psychopharmacology (Berl). 2009 Jun;204(2):265-77. doi: 10.1007/s00213-008-1457-4. Epub 2009 Jan 24.

6.

Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements.

Schmidt WJ, Lebsanft H, Heindl M, Gerlach M, Gruenblatt E, Riederer P, Mayerhofer A, Scheller DK.

J Neural Transm (Vienna). 2008 Oct;115(10):1385-92. doi: 10.1007/s00702-008-0102-z. Epub 2008 Aug 23.

PMID:
18726139
7.

Clozapine and olanzapine but not risperidone impair the pre-frontal striatal system in relation to egocentric spatial orientation in a Y-maze.

Castro CC, Dos Reis-Lunardelli EA, Schmidt WJ, Coitinho AS, Izquierdo I.

Curr Neurovasc Res. 2007 Nov;4(4):235-9.

PMID:
18045148
8.
9.
10.

Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence.

Bichelmeier U, Schmidt T, Hübener J, Boy J, Rüttiger L, Häbig K, Poths S, Bonin M, Knipper M, Schmidt WJ, Wilbertz J, Wolburg H, Laccone F, Riess O.

J Neurosci. 2007 Jul 11;27(28):7418-28.

11.

Comparison of the mGluR1 antagonist A-841720 in rat models of pain and cognition.

Morè L, Gravius A, Pietraszek M, Belozertseva I, Malyshkin A, Shekunova E, Barberi C, Schaefer D, Schmidt WJ, Danysz W.

Behav Pharmacol. 2007 Jul;18(4):273-81.

PMID:
17551319
12.

Behavioural sensitization in addiction, schizophrenia, Parkinson's disease and dyskinesia.

Schmidt WJ, Beninger RJ.

Neurotox Res. 2006 Oct;10(2):161-6. Review.

PMID:
17062377
13.
14.
15.

A rat model of Parkinsonism shows depletion of dopamine in the retina.

Biehlmaier O, Alam M, Schmidt WJ.

Neurochem Int. 2007 Jan;50(1):189-95. Epub 2006 Sep 8.

16.

The role of group I metabotropic glutamate receptors in acquisition and expression of contextual and auditory fear conditioning in rats - a comparison.

Gravius A, Barberi C, Schäfer D, Schmidt WJ, Danysz W.

Neuropharmacology. 2006 Dec;51(7-8):1146-55. Epub 2006 Aug 14.

PMID:
16905160
17.

The neuroprotectant properties of glutamate antagonists and antiglutamatergic drugs.

Pedersen V, Schmidt WJ.

Neurotox Res. 2000;2(2-3):179-204.

PMID:
16787840
18.

Functional interaction of NMDA and group I metabotropic glutamate receptors in negatively reinforced learning in rats.

Gravius A, Pietraszek M, Schmidt WJ, Danysz W.

Psychopharmacology (Berl). 2006 Mar;185(1):58-65. Epub 2006 Jan 10.

PMID:
16402194
19.

Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis.

Waltereit R, Welzl H, Dichgans J, Lipp HP, Schmidt WJ, Weller M.

J Neurochem. 2006 Jan;96(2):407-13. Epub 2005 Nov 21.

20.

Effects of MPEP on expression of food-, MDMA- or amphetamine-conditioned place preference in rats.

Herzig V, Capuani EM, Kovar KA, Schmidt WJ.

Addict Biol. 2005 Sep;10(3):243-9.

PMID:
16109585
21.

Repeated Catha edulis oral administration enhances the baseline aggressive behavior in isolated rats.

Banjaw MY, Miczek K, Schmidt WJ.

J Neural Transm (Vienna). 2006 May;113(5):543-56. Epub 2005 Aug 5.

PMID:
16082505
22.

Integrative proteomics: functional and molecular characterization of a particular glutamate-related neuregulin isoform.

Schillo S, Pejović V, Hunzinger C, Hansen T, Poznanović S, Kriegsmann J, Schmidt WJ, Schrattenholz A.

J Proteome Res. 2005 May-Jun;4(3):900-8.

PMID:
15952737
23.

3,4-Methylenedioxymethamphetamine and naloxone in rat rotational behaviour and open field.

Lebsanft HB, Kovar KA, Schmidt WJ.

Eur J Pharmacol. 2005 May 23;516(1):34-9.

PMID:
15899478
24.
25.

Repeated-testing of place preference expression for evaluation of anti-craving-drug effects.

Herzig V, Schmidt WJ.

Amino Acids. 2005 May;28(3):309-17. Epub 2005 Mar 30.

PMID:
15791393
26.

Effects of mGlu1 and mGlu5 receptor antagonists on negatively reinforced learning.

Gravius A, Pietraszek M, Schäfer D, Schmidt WJ, Danysz W.

Behav Pharmacol. 2005 Mar;16(2):113-21.

PMID:
15767847
29.

3,4-Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy.

Lebsanft HB, Kohles T, Kovar KA, Schmidt WJ.

Synapse. 2005 Mar 1;55(3):148-55.

PMID:
15602749
30.

Behavioural sensitisation following repeated intermittent oral administration of Catha edulis in rats.

Banjaw MY, Schmidt WJ.

Behav Brain Res. 2005 Jan 30;156(2):181-9.

PMID:
15582104
31.
32.

Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine.

Herzig V, Schmidt WJ.

Neuropharmacology. 2004 Dec;47(7):973-84.

PMID:
15555632
33.
35.

L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats.

Alam M, Schmidt WJ.

Behav Brain Res. 2004 Aug 31;153(2):439-46.

PMID:
15265640
36.

The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?

Srinivasan J, Schmidt WJ.

Naunyn Schmiedebergs Arch Pharmacol. 2004 Jun;369(6):629-38. Epub 2004 Apr 29.

PMID:
15118809
38.

The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA.

Alam M, Mayerhofer A, Schmidt WJ.

Behav Brain Res. 2004 May 5;151(1-2):117-24.

PMID:
15084427
39.

Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain.

Bashkatova V, Alam M, Vanin A, Schmidt WJ.

Exp Neurol. 2004 Apr;186(2):235-41.

PMID:
15026259
40.
41.
43.

Context-dependent catalepsy intensification is due to classical conditioning and sensitization.

Amtage J, Schmidt WJ.

Behav Pharmacol. 2003 Nov;14(7):563-7.

PMID:
14557724
44.

Burst activity of spiny projection neurons in the striatum encodes superimposed muscle tetani in cataleptic rats.

Frank ST, Schmidt WJ.

Exp Brain Res. 2003 Oct;152(4):519-22. Epub 2003 Aug 30.

PMID:
14513187
45.
46.

The effect of acamprosate on the development of morphine-induced behavioral sensitization in rats.

Kratzer U, Spanagel R, Schmidt WJ.

Behav Pharmacol. 2003 Jul;14(4):351-6.

PMID:
12838041
47.

Anticataleptic activity of cathinone and MDMA (Ecstasy) upon acute and subchronic administration in rat.

Banjaw MY, Mayerhofer A, Schmidt WJ.

Synapse. 2003 Sep 15;49(4):232-8.

PMID:
12827642
49.

Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?

Lebsanft HB, Mayerhofer A, Kovar KA, Schmidt WJ.

J Neural Transm (Vienna). 2003 Jul;110(7):707-18.

PMID:
12811632
50.

Acamprosate does not induce a conditioned place preference and reveals no state-dependent effects in this paradigm.

Kratzer U, Schmidt WJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Jun;27(4):653-6.

PMID:
12787853

Supplemental Content

Loading ...
Support Center